209 related articles for article (PubMed ID: 38270191)
1. The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the γ-Subunit Gng2.
Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hébert S; Wai Lam Poon W; Aryanpour Z; Zhang T; Zahedi RP; Boulais J; Buchwald ZS; Borchers CH; Côté JF; Kleinman CL; Mandl JN; Orthwein A
Mol Cell Biol; 2024 Jan; 44(1):1-16. PubMed ID: 38270191
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
[TBL] [Abstract][Full Text] [Related]
3. OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1.
Jahan AS; Biquand E; Muñoz-Moreno R; Le Quang A; Mok CK; Wong HH; Teo QW; Valkenburg SA; Chin AWH; Man Poon LL; Te Velthuis A; García-Sastre A; Demeret C; Sanyal S
Cell Rep; 2020 Feb; 30(5):1570-1584.e6. PubMed ID: 32023470
[TBL] [Abstract][Full Text] [Related]
4. OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3.
Herhaus L; Al-Salihi M; Macartney T; Weidlich S; Sapkota GP
Nat Commun; 2013; 4():2519. PubMed ID: 24071738
[TBL] [Abstract][Full Text] [Related]
5. OTUB1 non-catalytically stabilizes the E2 ubiquitin-conjugating enzyme UBE2E1 by preventing its autoubiquitination.
Pasupala N; Morrow ME; Que LT; Malynn BA; Ma A; Wolberger C
J Biol Chem; 2018 Nov; 293(47):18285-18295. PubMed ID: 30282802
[TBL] [Abstract][Full Text] [Related]
6. OTUB1 modulates c-IAP1 stability to regulate signalling pathways.
Goncharov T; Niessen K; de Almagro MC; Izrael-Tomasevic A; Fedorova AV; Varfolomeev E; Arnott D; Deshayes K; Kirkpatrick DS; Vucic D
EMBO J; 2013 Apr; 32(8):1103-14. PubMed ID: 23524849
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Cross-Regulation by Different OTUB1:E2 Complexes.
Que LT; Morrow ME; Wolberger C
Biochemistry; 2020 Mar; 59(8):921-932. PubMed ID: 32049508
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1.
Zhu D; Xu R; Huang X; Tang Z; Tian Y; Zhang J; Zheng X
Cell Death Differ; 2021 Jun; 28(6):1773-1789. PubMed ID: 33328570
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of OTUB1-mediated inhibition of ubiquitination.
Wiener R; Zhang X; Wang T; Wolberger C
Nature; 2012 Feb; 483(7391):618-22. PubMed ID: 22367539
[TBL] [Abstract][Full Text] [Related]
10. OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6.
Zhao Y; Ruan J; Li Z; Su X; Chen K; Lin Y; Cai Y; Wang P; Liu B; Schlüter D; Liang G; Wang X
Clin Transl Med; 2023 Aug; 13(8):e1385. PubMed ID: 37608493
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.
Kumar P; Kumar P; Mandal D; Velayutham R
Front Cell Infect Microbiol; 2022; 12():985178. PubMed ID: 36237424
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway.
Ye D; Wang S; Wang X; Lin Y; Huang Y; Chi P
Bioengineered; 2022 Apr; 13(4):9106-9116. PubMed ID: 35354355
[TBL] [Abstract][Full Text] [Related]
14. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.
Wang P; Joberty G; Buist A; Vanoosthuyse A; Stancu IC; Vasconcelos B; Pierrot N; Faelth-Savitski M; Kienlen-Campard P; Octave JN; Bantscheff M; Drewes G; Moechars D; Dewachter I
Acta Neuropathol; 2017 May; 133(5):731-749. PubMed ID: 28083634
[TBL] [Abstract][Full Text] [Related]
15. Lysophospholipids control integrin-dependent adhesion in splenic B cells through G(i) and G(12)/G(13) family G-proteins but not through G(q)/G(11).
Rieken S; Herroeder S; Sassmann A; Wallenwein B; Moers A; Offermanns S; Wettschureck N
J Biol Chem; 2006 Dec; 281(48):36985-92. PubMed ID: 17023430
[TBL] [Abstract][Full Text] [Related]
16. Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability.
Lee SG; Woo SM; Seo SU; Lee HS; Kim SH; Chang YC; Cho HJ; Yook S; Nam JO; Kwon TK
Oncogene; 2024 Jun; 43(24):1852-1860. PubMed ID: 38664499
[TBL] [Abstract][Full Text] [Related]
17. Breaking the chains: deubiquitylating enzyme specificity begets function.
Clague MJ; Urbé S; Komander D
Nat Rev Mol Cell Biol; 2019 Jun; 20(6):338-352. PubMed ID: 30733604
[TBL] [Abstract][Full Text] [Related]
18. The deubiquitinase Otub1 controls the activation of CD8
Zhou X; Yu J; Cheng X; Zhao B; Manyam GC; Zhang L; Schluns K; Li P; Wang J; Sun SC
Nat Immunol; 2019 Jul; 20(7):879-889. PubMed ID: 31182807
[TBL] [Abstract][Full Text] [Related]
19. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.
Saldana M; VanderVorst K; Berg AL; Lee H; Carraway KL
Endocr Relat Cancer; 2019 Jan; 26(1):R1-R14. PubMed ID: 30400005
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition and deubiquitination of cyclic K48-linked ubiquitin chains by OTUB1.
Sorada T; Morimoto D; Walinda E; Sugase K
Biochem Biophys Res Commun; 2021 Jul; 562():94-99. PubMed ID: 34049206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
